Topoisomerase II inhibitor 4

Modify Date: 2025-08-26 19:32:39

Topoisomerase II inhibitor 4 Structure
Topoisomerase II inhibitor 4 structure
Common Name Topoisomerase II inhibitor 4
CAS Number 2560590-49-8 Molecular Weight 459.50
Density N/A Boiling Point N/A
Molecular Formula C25H25N5O4 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Topoisomerase II inhibitor 4


Topoisomerase II inhibitor 4 (compound E17) is a potent Topoisomerase II inhibitor. Topoisomerase II inhibitor 4 triggers G2/M cell cycle arrest and shows anti-tumor activity with strong cytotoxic and anti-proliferative effect[1].

 Names

Name Topoisomerase II inhibitor 4

 Topoisomerase II inhibitor 4 Biological Activity

Description Topoisomerase II inhibitor 4 (compound E17) is a potent Topoisomerase II inhibitor. Topoisomerase II inhibitor 4 triggers G2/M cell cycle arrest and shows anti-tumor activity with strong cytotoxic and anti-proliferative effect[1].
Related Catalog
Target

Topoisomerase II

In Vitro Topoisomerase II inhibitor 4 (compound E17) inhibits cancer cells with IC50 values of 4.55 μM (MDA-MB-231), 6.61 μM (A549), 2.18 μM (KG1)[1]. Topoisomerase II inhibitor 4 (1 μM; 0-22 h) induces G2/M cell cycle arrest[2]. Topoisomerase II inhibitor 4 (5 μM; 4 h) inhibits topo II-mediated chromosomes condensation in CRC cells, while also (100 μM; 0.5, 1, 2 h) induces topo II–DNA complex accumulation without degradation of topo II[2]. Topoisomerase II inhibitor 4 (1 μM; 4 h) exerts anti-tumor activity without increasing gH2AX levels in HCT116, while no DNA damage and apoptosis as well [2]. Cell Migration Assay [2] Cell Line: HCT116, and WI-38 cells Concentration: 0.4, 0.6, 0.8, 1.0, 1.2 μM Incubation Time: 0, 12, 24, 48 hours Result: Resulted migration inhibition in HCT116 and SW480 cells. Cell Viability Assay[2] Cell Line: HCT116, and WI-38 cells Concentration: 0.39, 0.78, 1.56, 3.12, 6.25, 12.5, 25 μM Incubation Time: 72 hours Result: Exerted anti-proliferative effect in a dose-dependent manner.
References

[1]. Li ZY, et al. Structural optimizations and bioevaluation of N-substituted acridone derivatives as strong topoisomerase II inhibitors. Bioorg Chem. 2022 Feb. 119:105543.

[2]. Chen JN, et al. E17 exerts anti-tumor activity through inhibiting topo II-mediated chromosomes condensation in CRC cells. Biochem Biophys Res Commun. 2019 May 28. 513(2):313-318.

 Chemical & Physical Properties

Molecular Formula C25H25N5O4
Molecular Weight 459.50
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.